PAPER Armon C
SEARCH RESULTS
16106 RESULTS
PAPER Ahmed RM, Devenney EM, Strikwerda-Brown C, Hodges JR, Piguet O, Kiernan MC
COG-01 Phenotypic variation in ALS-FTD and effect on survival.
Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(sup1):301-308. PubMed: 31702468PAPER Roggenbuck J, Doyle C, Lincoln T, Glass J
Theme 2 Genetics and genomics.
Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(sup1):114-134. PubMed: 31702465PAPER Gieseler A, Hillert R, Krusche A, Zacher KH
Theme 5 Human cell biology and pathology.
Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(sup1):188-205. PubMed: 31702463PAPER Garnaas KR, Kittelsrud J, Behnke M
Theme 6 Tissue biomarkers.
Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(sup1):206-216. PubMed: 31702462PAPER Crook A, Hogden A, Mumford V, Blair IP, Williams KL, Rowe DB
CMS-01 Genetic testing for familial amyotrophic lateral sclerosis (ALS): insights and challenges.
Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(sup1):327-347. PubMed: 31702461PAPER Yang S, Wu S, Fifita J, McCann E, Fat SC, Galper J, Freckleton S, Zhang KY, Blair IP
Theme 3 In vitro experimental models.
Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(sup1):135-159. PubMed: 31702460PAPER Chudinova AV, Rossel M, Vergunst A, Le-Masson G, Camu W, Raoul C, Lumbroso S, Mouzat K
Theme 4 In vivo experimental models.
Amyotroph Lateral Scler Frontotemporal Degener. 2019 Nov;20(sup1):160-187. PubMed: 31702459PAPER Oeckl P, Weydt P, Thal DR, Weishaupt JH, Ludolph AC, Otto M
Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis.
Acta Neuropathol. 2020 Jan;139(1):119-134. Epub 2019 Nov 7 PubMed: 31701227PAPER Yang F, Zhang W, Jiang Y, Yin F, Han W, Li Z
Targeting the Amyloid-β Fibril Surface with a Constrained Helical Peptide Inhibitor.
Biochemistry. 2020 Jan 28;59(3):290-296. Epub 2019 Nov 18 PubMed: 31702899PAPER Tonali N, Dodero VI, Kaffy J, Hericks L, Ongeri S, Sewald N
Real-Time BODIPY-Binding Assay To Screen Inhibitors of the Early Oligomerization Process of Aβ1-42 Peptide.
Chembiochem. 2020 Apr 17;21(8):1129-1135. Epub 2020 Jan 9 PubMed: 31702868PAPER Xing S, Hu Y, Huang X, Shen D, Chen C
Nicotinamide phosphoribosyltransferase‑related signaling pathway in early Alzheimer's disease mouse models.
Mol Med Rep. 2019 Dec;20(6):5163-5171. Epub 2019 Oct 30 PubMed: 31702813PAPER Ferrari BL, Neto GC, Nucci MP, Mamani JB, Lacerda SS, Felício AC, Amaro E Jr, Gamarra LF
The accuracy of hippocampal volumetry and glucose metabolism for the diagnosis of patients with suspected Alzheimer's disease, using automatic quantitative clinical tools.
Medicine (Baltimore). 2019 Nov;98(45):e17824. PubMed: 31702636PAPER Karim N, Khan H, Khan I, Guo O, Sanchez ES, Rastrelli L, Kamal MA
An increasing role of polyphenols as novel therapeutics for Alzheimer's: A review.
Med Chem. 2019 Nov 5; PubMed: 31702507PAPER Ha ZY, Mathew S, Yeong KY
Butyrylcholinesterase: A Multifaceted Pharmacological Target and Tool.
Curr Protein Pept Sci. 2020;21(1):99-109. PubMed: 31702488Current Filters
- Date Range : Nov 2018 to Nov 2019 x